Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer Evolution During Neoadjuvant Systemic Therapy

NCT06681064 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT06681064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06681064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer Evolution During Neoadjuvant Systemic Therapy
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Recruiting
Start date
May 29, 2024
Completion date
May 31, 2034
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, er+ breast cancer, her2+ breast cancer, triple negative breast cancer